Evaluate the Effect of Dietary Supplement Combined Exercise Among Patients With Sarcopenia Comorbid With Lung Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorOrient Europharma Co., Ltd.

About this trial

This trial is a prospective multi-center study. The purpose of this study is to evaluate the effect of dietary supplement combined with supervised exercised on the physical performance, body composition and lung function among patients with Sarcopenia and severe Sarcopenia in chronic lung disease. After participants enroll in this study, 12-week clinical trial will be conducted to analyze the improvement regarding Sarcopenia and different severity of Sarcopenia before and after the intervention of exercise and nutritional products, which can further provide reference for clinical intervention and rehabilitation.

Eligibility criteria

Qualifiers

Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from Department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment.

Outpatients who meet the diagnostic criteria for Sarcopenia after evaluation by a physician.

Disqualifiers

Patients who refuse to sign the consent form

Patients who are under 20 years old

Patients who are bedridden or unable to walk due to physical disabilities

Patients with terminal cancer or human-acquired immunodeficiency syndrome

Trial design

Treatments tested in this trial

  • Sarcojoint®
  • supervised exercise

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators